Crossmark

Development and evaluation of a novel fast broad-range PCR and sequencing assay (FBR-PCR/S) using dual priming oligonucleotides targeting the ITS/LSU gene regions for rapid diagnosis of invasive fungal diseases: multi-year experience in a large Canadian healthcare zone

Crossref DOI link: https://doi.org/10.1186/s12879-022-07356-9

Published Online: 2022-04-13

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chow, B.

Groeschel, M.

Carson, J.

Griener, T.

Church, D. L.
License Information

Text and Data Mining valid from 2022-04-13

Version of Record valid from 2022-04-13
More Information

Article History

Received: 22 October 2021

Accepted: 6 April 2022

First Online: 13 April 2022

Declarations

:

: The study was approved, and a waiver of informed consent was granted by the Conjoint Health Ethics Research Board (CHREB), Alberta Health Services, and the University of Calgary (Ethics ID: E-23969). All methods were carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: None of the authors have a conflict of interest.

Document is current

Any future updates will be listed below